REGIS HEALTHCARE LIMITED (REG)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

REG

REG - REGIS HEALTHCARE LIMITED

FNArena Sector : Aged Care & Seniors
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 0.04
Index: ASX300 | ALL-ORDS

Regis Healthcare owns and operates residential aged-care homes across Australia, providing permanent, respite, dementia and palliative care services.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.77

19 Nov
2026

0.120

OPEN

$4.55

2.58%

HIGH

$4.79

776,671

LOW

$4.55

TARGET
$5.883 23.3% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EGH . INA . LIC . OCA . RYM . SNZ .
FNARENA'S MARKET CONSENSUS FORECASTS
REG: 1
Title FY25
Actual
FY26
Actual
FY27
Forecast
FY28
Forecast
EPS (cps) xxx 18.4 18.4 xxx
DPS (cps) xxx 18.4 19.2 xxx
EPS Growth xxx 13.5% - 0.2% xxx
DPS Growth xxx 13.4% 4.2% xxx
PE Ratio xxx N/A 25.1 xxx
Dividend Yield xxx N/A 4.1% xxx
Div Pay Ratio(%) xxx 99.8% 104.2% xxx

Dividend yield today if purchased 3 years ago: 6.76%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.98

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

$ 

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 08/09 - ex-div 9.40c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx18.4
DPS All xxxxxxxxxxxxxxx18.4
Sales/Revenue xxxxxxxxxxxxxxx1,343.6 M
Book Value Per Share xxxxxxxxxxxxxxx-4.0
Net Operating Cash Flow xxxxxxxxxxxxxxx336.3 M
Net Profit Margin xxxxxxxxxxxxxxx4.14 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx-
Return on Invested Capital xxxxxxxxxxxxxxx-
Return on Assets xxxxxxxxxxxxxxx2.37 %
Return on Equity xxxxxxxxxxxxxxx-
Return on Total Capital xxxxxxxxxxxxxxx-
Free Cash Flow ex dividends xxxxxxxxxxxxxxx142.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx3 M
Total Debt xxxxxxxxxxxxxxx4 M
Goodwill - Gross xxxxxxxxxxxxxxx695 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx174 M
Price To Book Value xxxxxxxxxxxxxxx-

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx142.0 M
Capex % of Sales xxxxxxxxxxxxxxx10.57 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,191 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx102 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx127 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

03/09/2026

3

Neutral

$5.95

24.74%

UBS notes the aged care funding outcome was well below expectations for FY27 with the headline pricing increase advised at 2.55% compared with 4.7% in September 2025.

This is considered well short of the cost inflation faced by Regis Healthcare and other providers of residential aged care. The broker reduces EPS estimates by -14% to reflect the outcome while assuming modest cost savings can be achieved.

While still envisaging appeal in the supply/demand dynamics of the sector, this latest outcome reduces the attractiveness for investors in the sector, UBS asserts.

The broker suspects the government is intent on reducing the margin from the provision of care, with providers expected to generate returns from non-care sources. Neutral rating retained. Target price slips to $5.95 from $6.75.

FORECAST
UBS forecasts a full year FY27 dividend of 19.00 cents and EPS of 19.00 cents.
UBS forecasts a full year FY28 dividend of 24.00 cents and EPS of 24.00 cents.

Ord Minnett

xx/xx/xxxx

3

xxxxxxxxx xx xxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

19/11/2026

3

Neutral

$6.20

29.98%

Jarden maintains a Neutral rating for Regis Healthcare with a $6.20 target price following an annual general meeting update detailing 1Q27 operational performance.

Average occupancy held steady at 95.6% in 1Q27 alongside a 7% rise in average incoming full refundable accommodation deposits (RADs) to $750k after August room price increases of around 10%, while net RAD inflows softened in favour of Daily Accommodation Payments (DAPs) amid slower property market conditions.

Existing residents were transitioned to the Higher Everyday Living Fee ahead of the 1 November deadline, while refurbishment plans across 1,000 existing beds and the opening of the 123-bed Toowong greenfield facility with roughly 24% day-one occupancy support ongoing growth.

Jarden views management's swift cost response and rising DAP contributions positively for FY27 earnings, though the shift away from RAD inflows is regarded as a slight negative as Jarden retains its $6.20 discounted cash flow valuation pending clearer visibility on offsetting the funding shortfall.

REG STOCK CHART